Expressions of vascular endothelial growth factor (VEGF)-D and VEGF receptor-3 in colorectal cancer: Relationship to lymph node metastasis

Acta Medica Nagasakiensia

Volumn 47, Issue 3-4, 2002, Pages 155-160

  Haseba, Masatoshi ^a   Tsuji, Takashi ^b   Yano, Hiroshi ^b   Komatsu, Hideaki ^b   Hidaka, Shigekazu ^b   Sawai, Terumitsu ^b   Yasutake, Toru ^b   Nakagoe, Tohru ^b   Tagawa, Yutaka ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b NONE

Author keywords

Colorectal cancer; Lymph node metastasis; Lymphangiogenesis; Vascular endothelial growth factor (VEGF) D

Indexed keywords

UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

ADULT; AGED; ARTICLE; CANCER INVASION; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TUMOR CELL;

EID: 0036964858     PISSN: 00016055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Jeltsch M, Kaipainen A, Joukov V, et al: Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276: 1423-1425, 1997
2. Achen MG, Jeltsch M, Kukk E, et al: Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flkl) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95: 548-553, 1998
3. Joukov V, Pajusola K, Kaipainen A, et al: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15: 290-298, 1996
4. Kaipainen A, Korhonen J, Mustonen T, et al: Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92: 3566-3570, 1995
5. Kukk E, Lymboussaki A, Taira S, et al: VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122: 3829-3837, 1996
6. Veikkola T, Jussila L, Makinen T, et al: Signalling via vascular en dothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 20: 1223-1231, 2001
7. Orlandini M, Marconcini L, Ferruzzi R, Oliviero S: Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA 93: 11675-11680, 1996
8. Joukov V, Sorsa T, Kumar V, et al: Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 16: 3898-3911, 1997
9. Stacker SA, Stenvers K, Caesar C, et al: Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem 274: 32127-32136, 1999
10. Mandriota SJ, Jussila L, Jeltsch M, et al: Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20: 672-682, 2001
11. Skobe M, Hawighorst T, Jackson DG, et al: Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7: 192-198, 2001
12. Stacker SA, Caesar C, Baldwin ME, et al: VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7: 186-191, 2001
13. Achen MG, Williams RA, Minekus MP, et al: Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis. J Pathol 193: 147-154, 2001
14. Kurebayashi J, Otsuki T, Kunisue H, et al: Expression of vascular endothelial growth factor (VEGF) family members in breast cancer. Jpn J Cancer Res 90: 977-981, 1999
15. White JD, Hewett PW, Kosuge D, et al: Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res 62: 1669-1675, 2002
16. Fleming ID, Cooper JS, Henson DE, et al: Colon and Rectum. In: AJCC Cancer Staging Manual, fifth ed. (Fleming ID, Cooper JS, Henson DE, Hunter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH, Yarbro JW eds.; Lippincott-Raven, New York) pp. 83-90, 1997
17. VeikkoIa T, Karkkainen M, Claesson-Welsh L, Alitalo K: Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res 60: 203-212. 2000
18. Beck L Jr., D'Amore PA: Vascular development: cellular and molecular regulation. FASEB J 11: 365-373, 1997
19. Ellis LM, Fidler IJ: Angiogenesis and metastasis. Eur J Cancer 32A: 2451-2460, 1996
20. Baldwin ME. Catimel B, Nice EC, et al: The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man. J Biol Chem 276: 19166-19171, 2001
21. Dumont DJ, Jussila L, Taipale J. et al: Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282: 946-949, 1998
22. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25, 1997
23. Niki T, Iba S, Tokunou M, et al: Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res 6: 2431-2439, 2000
24. O-Charoenrat P, Rhys-Evans P, Eccles SA: Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 92: 556-568, 2001
25. George ML, Tutton MG, Janssen F, et al: VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. Neoplasia 3: 420-427, 2001
26. Witte D, Thomas A, Ali N, Carlson N, Younes M: Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma. Anticancer Res 22: 1463-1466, 2002